CHINA BIOPHARMACEUTICALS COMPLETES ENSHI PHARMA ACQUISITION

A A

Chinese pharmaceutical company, China Biopharmaceuticals Holdings Inc. (CHBP) has completed the acquisition of all of the shares in RACP Pharmaceutical Holdings Ltd., and its wholly owned subsidiaries, including Shenyang Enshi Pharmaceutical Co. Ltd. from RimAsia Capital Partners LP.

BioSpectrum Asia (http://www.biospectrumasia.com/content/060706CHN1073.asp)